Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE)Devaki Shilpa Surasi, Morand Piert, Soroush Rais‐Bahrami et al.|European Urology|2023Cited by 90
Shedding of RANKL by Tumor-Associated MT1-MMP Activates Src-Dependent Prostate Cancer Cell MigrationAaron Sabbota, Michael L. Cher|Cancer Research|2010Cited by 83
Prostate Cancer-Associated Membrane Type 1-Matrix MetalloproteinaseR. Daniel Bonfil, Michael L. Cher|American Journal Of Pathology|2007Cited by 72
Diagnostic Performance and Safety of <sup>18</sup> F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT)Ashesh B. Jani, Katherine Zukotynski, Gregory Ravizzini et al.|The Journal of Urology|2023Cited by 65